PANAGORA ASSET MANAGEMENT INC

Position in KALV — KalVista Pharmaceuticals, Inc.

CIK 883677 Boston, MA

Position in KALV

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,022,442

-$744,222 QoQ

Shares Held

50,792

-53.6% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#77

of 182 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 57.14285714285714.ToString("F0")% Shared 0.ToString("F0")% None 42.857142857142854.ToString("F0")%

Healthcare · as of Mar 31, 2026

PANAGORA ASSET MANAGEMENT INC holds $504,243,073 across 65 Biotechnology names. KALV ranks #37 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,210,909	$113,970,755
2	REGN	Regeneron Pharmaceuticals, Inc.	105,225	$81,301,044
3	BBIO	BridgeBio Pharma, Inc.	742,117	$55,109,608
4	ARWR	Arrowhead Pharmaceuticals, Inc.	461,193	$28,916,801
5	JAZZ	Jazz Pharmaceuticals plc	143,499	$27,128,485
6	PTCT	Ptc Therapeutics, Inc.	351,370	$23,938,838
7	TVTX	Travere Therapeutics, Inc.	592,912	$17,615,415
8	ONC	BeOne Medicines Ltd.	57,320	$17,022,320

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,022,442	50,792	-53.6%	Shares	Sole	2026-05-14
2025-12-31	$1,766,664	109,391	-44.6%	Shares	Sole	2026-02-13
2025-09-30	$2,403,540	197,335	-32.6%	Shares	Sole	2025-11-13
2025-06-30	$3,307,763	292,593	+307.0%	Shares	Sole	2025-08-13
2025-03-31	$829,679	71,896	0.0%	Shares	Sole	2025-05-15
2024-12-31	$608,959	71,896	+213.4%	Shares	Sole	2025-02-13
2023-09-30	$220,921	22,941	-12.1%	Shares	Sole	2023-10-31
2023-06-30	$234,810	26,090	-43.6%	Shares	Sole	2023-08-11
2023-03-31	$363,517	46,249	+145.1%	Shares	Sole	2023-05-12
2022-12-31	$127,547	18,868	+6687.1%	Shares	Sole	2023-02-13
2021-06-30	$6,660	278	-7.6%	Shares	Sole	2021-08-11
2021-03-31	$7,732	301	0.0%	Shares	Sole	2021-05-12
2020-12-31	$5,715	301	—	Shares	Sole	2021-02-10
No filing history on record for this holder in this stock.